{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:11:28Z","timestamp":1788844288556,"version":"build-2803163510"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gedeon Richter, Plc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Schizophrenia is marked by persistent negative and cognitive symptoms that remain difficult to treat. Cariprazine, a dopamine D3\/D2 partial agonist, has demonstrated efficacy in these domains, making it essential to clarify its neurophysiological mechanisms both for future drug discovery and clinical application. Resting-state EEG spectral analysis provides a non-invasive and translational tool for monitoring neurophysiological changes related to treatment. However, data on EEG spectral effects in human patients treated with cariprazine are currently lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this open-label investigation, 27 patients with schizophrenia underwent high-density resting-state EEG before and during cariprazine treatment. Power spectral analyses were conducted across frequency bands and cortical regions, with ROI analyses targeting gamma-activity in DLPFC, IFG, and TPJ. Symptom changes were measured using the Positive and Negative Syndrome Scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cariprazine treatment led to symptom improvement, particularly in negative and general domains. EEG analyses showed increased spectral power, most prominently in the theta and alpha bands, mirroring findings from the only available in vivo preclinical study, which also reported theta and alpha elevations in rodents. Symptom reduction was specifically associated with increased theta and decreased delta power. Moreover, baseline gamma-activity\u2014especially in the IFG and DLPFC\u2014predicted treatment response, with Receiver Operating Characteristic analyses yielding AUC values of 0.72-0.92 and cross-validated classification accuracies exceeding 70%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Together, our results demonstrate that resting-state EEG spectral measures reflect neurophysiological correlates of cariprazine response. Furthermore, the findings reinforce the cross-species translatability of spectral measures and support EEG biomarkers as promising translational tools for predicting and monitoring treatment outcomes in schizophrenia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ijnp\/pyag008","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:53:58Z","timestamp":1772628838000},"source":"Crossref","is-referenced-by-count":2,"title":["High-density EEG study in patients with schizophrenia treated with cariprazine"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6361-8006","authenticated-orcid":false,"given":"P\u00e1l","family":"Czobor","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Semmelweis University , Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitta","family":"Kakuszi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Semmelweis University , Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1t\u00e9","family":"Fullajt\u00e1r","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Semmelweis University , Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Bitter","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Semmelweis University , Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"2026040801023748100_ref1","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1016\/j.bmcl.2012.03.104","article-title":"Discovery of cariprazine (RGH-188): a novel antipsychotic acting on dopamine D3\/D2 receptors","volume":"22","author":"Agai-Csongor","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"2026040801023748100_ref2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12325-013-0006-7","article-title":"Cariprazine in schizophrenia: clinical efficacy, tolerability, and place in therapy","volume":"30","author":"Citrome","year":"2013","journal-title":"Adv Ther"},{"key":"2026040801023748100_ref3","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0140-6736(17)30060-0","article-title":"Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial","volume":"389","author":"Nemeth","year":"2017","journal-title":"Lancet"},{"key":"2026040801023748100_ref4","first-page":"250","article-title":"Cariprazine modulates hippocampal gamma oscillations in vitro: potential involvement in schizophrenia symptoms","volume":"41","author":"Adham","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"2026040801023748100_ref5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.schres.2017.01.017","article-title":"Aberrant alpha and gamma oscillations ex vivo after single application of the NMDA receptor antagonist MK-801","volume":"188","author":"Lemercier","year":"2017","journal-title":"Schizophr Res"},{"key":"2026040801023748100_ref6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.neuron.2013.03.007","article-title":"The theta-gamma neural code","volume":"77","author":"Lisman","year":"2013","journal-title":"Neuron"},{"key":"2026040801023748100_ref7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-neuro-062012-170330","article-title":"Mechanisms and functions of theta rhythms","volume":"36","author":"Colgin","year":"2013","journal-title":"Annu Rev Neurosci"},{"key":"2026040801023748100_ref8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-neuro-062111-150444","article-title":"Mechanisms of gamma oscillations","volume":"35","author":"Buzsaki","year":"2012","journal-title":"Annu Rev Neurosci"},{"key":"2026040801023748100_ref9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.31887\/DCNS.2013.15.3\/puhlhaas","article-title":"High-frequency oscillations and the neurobiology of schizophrenia","volume":"15","author":"Uhlhaas","year":"2013","journal-title":"Dialogues Clin Neurosci"},{"key":"2026040801023748100_ref10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.biopsych.2014.11.019","article-title":"Oscillations and neuronal dynamics in schizophrenia: the search for basic symptoms and translational opportunities","volume":"77","author":"Uhlhaas","year":"2015","journal-title":"Biol Psychiatry"},{"key":"2026040801023748100_ref11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00406-018-0889-z","article-title":"Alterations in resting-state gamma activity in patients with schizophrenia: a high-density EEG study","volume":"269","author":"Baradits","year":"2018","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2026040801023748100_ref12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/0269881120981378","article-title":"Cariprazine modulates sleep architecture in rats","volume":"35","author":"Nyitrai","year":"2021","journal-title":"J Psychopharmacol"},{"key":"2026040801023748100_ref13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41537-023-00419-z","article-title":"Pharmaco-EEG of antipsychotic treatment response: a systematic review","volume":"9","author":"DePieri","year":"2023","journal-title":"Schizophrenia (Heidelb)"},{"key":"2026040801023748100_ref14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.9758\/cpn.2021.19.2.313","article-title":"Quantitative resting state electroencephalography in patients with schizophrenia Spectrum disorders treated with strict monotherapy using atypical antipsychotics","volume":"19","author":"Ozaki","year":"2021","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"2026040801023748100_ref15","doi-asserted-by":"publisher","first-page":"E461","DOI":"10.1503\/jpn.230081","article-title":"Meta-analysis of cortical thickness reduction in adult schizophrenia","volume":"48","author":"Sun","year":"2023","journal-title":"J Psychiatry Neurosci"},{"key":"2026040801023748100_ref16","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1093\/schbul\/sbu121","article-title":"Increased resting-state gamma-band connectivity in first-episode schizophrenia","volume":"41","author":"Andreou","year":"2015","journal-title":"Schizophr Bull"},{"key":"2026040801023748100_ref17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"2026040801023748100_ref18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0013-4694(82)90112-2","article-title":"Transformations towards the normal distribution of broad band spectral parameters of the EEG","volume":"53","author":"Gasser","year":"1982","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"2026040801023748100_ref19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0920-9964(00)00165-1","article-title":"Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment","volume":"50","author":"Knott","year":"2001","journal-title":"Schizophr Res"},{"key":"2026040801023748100_ref20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41537-023-00392-7","article-title":"A systematic review of neuroimaging studies of clozapine-resistant schizophrenia","volume":"9","author":"Pang","year":"2023","journal-title":"Schizophrenia (Heidelb)"},{"key":"2026040801023748100_ref21","doi-asserted-by":"publisher","first-page":"116040","DOI":"10.1016\/j.psychres.2024.116040","article-title":"Alterations in resting-state gamma-activity is adults with autism spectrum disorder: a high-density EEG study","volume":"339","author":"Kakuszi","year":"2024","journal-title":"Psychiatry Res"},{"key":"2026040801023748100_ref22","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4088\/JCP.v58n1205","article-title":"The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the north American trials","volume":"58","author":"Marder","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"2026040801023748100_ref23","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988","edition":"2"},{"key":"2026040801023748100_ref24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev.clinpsy.032408.153550","article-title":"Advances in analysis of longitudinal data","volume":"6","author":"Gibbons","year":"2010","journal-title":"Annu Rev Clin Psychol"},{"key":"2026040801023748100_ref25","doi-asserted-by":"crossref","DOI":"10.1002\/0471722146","volume-title":"Applied Logistic Regression","author":"Hosmer","year":"2000","edition":"2"},{"key":"2026040801023748100_ref26","doi-asserted-by":"publisher","first-page":"S255","DOI":"10.1192\/j.eurpsy.2025.565","article-title":"Relapse prevention with cariprazine: A focus on sex","volume":"68","author":"Correll","year":"2025","journal-title":"Eur Psychiatry"},{"key":"2026040801023748100_ref27","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1124\/mol.118.113290","article-title":"Involvement of 5-HT(1A) and 5-HT(2A) receptors but not alpha (2)-adrenoceptors in the acute electrophysiological effects of Cariprazine in the rat brain In vivo","volume":"94","author":"Herman","year":"2018","journal-title":"Mol Pharmacol"},{"key":"2026040801023748100_ref28","first-page":"802","article-title":"The importance of 5-HT1A receptor agonism in antipsychotic drug action: rationale and perspectives","volume":"11","author":"Newman-Tancredi","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"2026040801023748100_ref29","doi-asserted-by":"publisher","first-page":"1333711","DOI":"10.3389\/fpsyt.2024.1333711","article-title":"Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia","volume":"15","author":"Giordano","year":"2024","journal-title":"Front Psych"},{"key":"2026040801023748100_ref30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000154474","article-title":"LORETA functional imaging in antipsychotic-naive and olanzapine-, clozapine- and risperidone-treated patients with schizophrenia","volume":"58","author":"Tislerova","year":"2008","journal-title":"Neuropsychobiology"},{"key":"2026040801023748100_ref31","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/hup.537","article-title":"EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects","volume":"18","author":"Amann","year":"2003","journal-title":"Hum Psychopharmacol"},{"key":"2026040801023748100_ref32","doi-asserted-by":"publisher","first-page":"695","DOI":"10.30773\/pi.2019.06.20.1","article-title":"Predicting symptomatic and functional improvements over 1 year in patients with first-episode psychosis using resting-state electroencephalography","volume":"16","author":"Renaldi","year":"2019","journal-title":"Psychiatry Investig"},{"key":"2026040801023748100_ref33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0165-0173(98)00056-3","article-title":"EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis","volume":"29","author":"Klimesch","year":"1999","journal-title":"Brain Res Brain Res Rev"},{"key":"2026040801023748100_ref34","doi-asserted-by":"publisher","first-page":"e31375","DOI":"10.1371\/journal.pone.0031375","article-title":"Learning to learn: Theta oscillations predict new learning, which enhances related learning and neurogenesis","volume":"7","author":"Nokia","year":"2012","journal-title":"PLoS One"},{"key":"2026040801023748100_ref35","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3389\/fpsyt.2020.00661","article-title":"Altered cortical functional networks in patients with schizophrenia and bipolar disorder: a resting-state electroencephalographic study","volume":"11","author":"Kim","year":"2020","journal-title":"Front Psych"},{"key":"2026040801023748100_ref36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000443175","article-title":"Pharmaco-EEG studies in animals: a history-based introduction to contemporary translational applications","volume":"72","author":"Drinkenburg","year":"2015","journal-title":"Neuropsychobiology"},{"key":"2026040801023748100_ref37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000442210","article-title":"Pharmaco-EEG studies in animals: an overview of contemporary translational applications","volume":"72","author":"Drinkenburg","year":"2015","journal-title":"Neuropsychobiology"},{"key":"2026040801023748100_ref38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4306\/pi.2011.8.4.288","article-title":"Gamma oscillation in schizophrenia","volume":"8","author":"Shin","year":"2011","journal-title":"Psychiatry Investig"},{"key":"2026040801023748100_ref39","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1176\/jnp.6.4.348","article-title":"Working memory dysfunction in schizophrenia","volume":"6","author":"Goldman-Rakic","year":"1994","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2026040801023748100_ref40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.tics.2013.12.003","article-title":"Inhibition and the right inferior frontal cortex: one decade on","volume":"18","author":"Aron","year":"2014","journal-title":"Trends Cogn Sci"},{"key":"2026040801023748100_ref41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev.neuro.25.112701.142946","article-title":"Functional MRI of language: new approaches to understanding the cortical organization of semantic processing","volume":"25","author":"Bookheimer","year":"2002","journal-title":"Annu Rev Neurosci"},{"key":"2026040801023748100_ref42","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S1053-8119(03)00230-1","article-title":"People thinking about thinking people. The role of the temporo-parietal junction in ``theory of mind''","volume":"19","author":"Saxe","year":"2003","journal-title":"Neuroimage"},{"key":"2026040801023748100_ref43","doi-asserted-by":"publisher","first-page":"770234","DOI":"10.3389\/fpsyt.2021.770234","article-title":"Dosing Cariprazine within and beyond clinical trials: recommendations for the treatment of schizophrenia","volume":"12","author":"Rancans","year":"2021","journal-title":"Front Psych"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijnp\/advance-article-pdf\/doi\/10.1093\/ijnp\/pyag008\/67279378\/pyag008.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/article-pdf\/29\/4\/pyag008\/67279378\/pyag008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijnp\/article-pdf\/29\/4\/pyag008\/67279378\/pyag008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:02:43Z","timestamp":1775624563000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/doi\/10.1093\/ijnp\/pyag008\/8512081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyag008","relation":{},"ISSN":["1461-1457","1469-5111"],"issn-type":[{"value":"1461-1457","type":"print"},{"value":"1469-5111","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,9]]},"article-number":"pyag008"}}